Updates ·
Health notices · Friday 13 November
3 notices from the agencies today, in plain words, each with the original linked.
Aerocare Sani Mango antiseptic wash class II notice
FDA · Recall
If you used Aerocare Sani Mango Antiseptic Hand and Body Wash, the US Food and Drug Administration issued a Class II notice. Class II means the product could cause health problems, though serious harm is not expected in all cases.
The notice cites CGMP deviations. CGMP means “current good manufacturing practice,” the quality rules for how products are made. The wash was distributed nationwide in the US.
COVID-19 disrupted mental health services in many countries, WHO survey
World Health Organization (WHO) · News
If you need mental health, neurological, or substance use services, a new WHO survey reports that COVID-19 disrupted or halted many of these services in 93% of countries worldwide.
The survey found disruptions to counseling and psychotherapy, harm reduction services, emergency interventions, and access to medications. It also reports growing demand linked to bereavement, isolation, loss of income, fear, and COVID-19 complications.
Some countries used telemedicine or teletherapy to replace in-person care, but uptake varied widely. People with pre-existing mental, neurological, or substance use conditions may face higher vulnerability to infection and severe outcomes.
FDA approval for Zituvimet oral solution for type 2 diabetes
FDA · Approval
If you take ZITUVIMET, it is approved as an adjunct to diet and exercise to improve glycemic control (blood sugar control) in adults with type 2 diabetes mellitus.
ZITUVIMET is not recommended if you have type 1 diabetes mellitus. It has not been studied in people with a history of pancreatitis (inflammation of the pancreas), and the notice says the risk is unknown.
If you’re prescribed ZITUVIMET, follow the diet and exercise plan your clinician recommends alongside the medicine.
Where this comes from
- Aerocare Sani Mango antiseptic wash class II noticeUS Food and Drug Administration — enforcement report
- COVID-19 disrupted mental health services in many countries, WHO surveywho-news
- FDA approval for Zituvimet oral solution for type 2 diabetesUS Food and Drug Administration — Drugs@FDA
Each notice above is summarised from the agency's own publication, linked beside it. Nothing here is a finding of ours.